LexaGene Holdings Inc. (CVE:LXG – Get Free Report) was down 19.2% on Tuesday . The company traded as low as C$0.10 and last traded at C$0.11. Approximately 2,135,377 shares changed hands during mid-day trading, an increase of 1,156% from the average daily volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Price Performance
The company has a debt-to-equity ratio of 138.01, a current ratio of 1.39 and a quick ratio of 1.13. The stock has a market capitalization of C$14.77 million, a P/E ratio of -1.31 and a beta of 2.26. The company’s 50 day simple moving average is C$0.11 and its two-hundred day simple moving average is C$0.11.
LexaGene Company Profile
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
See Also
- Five stocks we like better than LexaGene
- Bank Stocks – Best Bank Stocks to Invest In
- Hasbro’s Management Made All the Right Calls This Quarter
- What is Short Interest? How to Use It
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- Overbought Stocks Explained: Should You Trade Them?
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
